Single dose kinetic study of the triple combination mefloquine/sulphadoxine/pyrimethamine (Fansimef) in healthy male volunteers.
about
The influence of pregnancy on the pharmacokinetic properties of artemisinin combination therapy (ACT): a systematic reviewResidual antimalarials in malaria patients from Tanzania--implications on drug efficacy assessment and spread of parasite resistanceAnticancer properties of distinct antimalarial drug classesAssociation between the pharmacokinetics and in vivo therapeutic efficacy of sulfadoxine-pyrimethamine in Malawian children.Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic studyPharmacokinetic properties of conventional and double-dose sulfadoxine-pyrimethamine given as intermittent preventive treatment in infancy.Study of treatment of congenital Toxoplasma gondii infection in rhesus monkeys with pyrimethamine and sulfadiazinePyrimethamine pharmacokinetics in human immunodeficiency virus-positive patients seropositive for Toxoplasma gondii.Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosisLevels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Toxoplasmosis Study GroupAdverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patientsPharmacokinetic properties of sulfadoxine-pyrimethamine in pregnant women.Clinical application of mefloquine pharmacokinetics in the treatment of P falciparum malaria.Population pharmacokinetics of pyrimethamine and sulfadoxine in children treated for congenital toxoplasmosis.Plasmodium falciparum: increased proportion of severe resistance (RII and RIII) to chloroquine and high rate of resistance to sulfadoxine-pyrimethamine in Peninsular Malaysia after two decades.Pharmacokinetic considerations for use of artemisinin-based combination therapies against falciparum malaria in different ethnic populations.
P2860
Q28079877-FD773C4E-F4CA-4215-A36F-D2669D97E268Q28472222-BB4425B5-0614-4A50-9798-9FF8BC1E71D4Q28538116-57091475-B152-4762-84B8-8C2E1E746476Q33935430-9D66EC95-B01D-450D-B48A-7A6ECCF00000Q34357744-9DA8085A-4736-46E2-9182-01CD2EF36D08Q34737758-23B4681E-EAFC-4884-A905-6F562F2F1FCFQ35110989-EF972374-415D-4BE4-BDBA-637EB0F79877Q35124802-E156138E-0E03-495F-B5C6-C62A48F58D8BQ35826163-D82F0C03-109F-4F39-9860-9CF39BC3827EQ35836203-DBCFD50F-6D72-4934-B479-B0D6A97D2012Q36278433-514A52DB-21C1-440E-AF69-CD1B7C4F7F53Q37392749-CEEC85CA-DEE5-4D89-847C-5CDE839A7A73Q39121228-8C7F7FEF-C5F6-4A43-B439-3E6959EF6E5EQ40165651-2B94F2AE-888D-406B-B115-4EC07099CC3FQ41930926-AD4D2B52-A986-482F-A9CF-D6710E7F098DQ46405195-4813D860-C890-4326-A25B-80478A75A0A4
P2860
Single dose kinetic study of the triple combination mefloquine/sulphadoxine/pyrimethamine (Fansimef) in healthy male volunteers.
description
1989 nî lūn-bûn
@nan
1989 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի մարտին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Single dose kinetic study of t ...... f) in healthy male volunteers.
@ast
Single dose kinetic study of t ...... f) in healthy male volunteers.
@en
Single dose kinetic study of the triple combination mefloquine/sulphadoxine/pyrimethamine
@nl
type
label
Single dose kinetic study of t ...... f) in healthy male volunteers.
@ast
Single dose kinetic study of t ...... f) in healthy male volunteers.
@en
Single dose kinetic study of the triple combination mefloquine/sulphadoxine/pyrimethamine
@nl
prefLabel
Single dose kinetic study of t ...... f) in healthy male volunteers.
@ast
Single dose kinetic study of t ...... f) in healthy male volunteers.
@en
Single dose kinetic study of the triple combination mefloquine/sulphadoxine/pyrimethamine
@nl
P2093
P2860
P1476
Single dose kinetic study of t ...... f) in healthy male volunteers.
@en
P2093
Jamaludin A
Navaratnam V
Wernsdorfer WH
P2860
P304
P356
10.1111/J.1365-2125.1989.TB05381.X
P407
P577
1989-03-01T00:00:00Z